🇺🇸 FDA

Company profile · Sponsor

Avalo

Avalo Therapeutics

AVTX · NYSE pharma WAYNE, PA, USA
Pipeline
17
Drugs
0
Patents
8

Quick answer

Avalo (AVTX) is a pharma company. headquartered in WAYNE, PA, USA. listed on NYSE. NovaPharmaNews links 17 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker AVTX
Exchange NYSE
Company type pharma
Headquarters WAYNE, PA, USA
SEC CIK 0001534120

Pipeline (17)

Search pipeline →

  1. NFC-1

    Avalo

    Attention Deficit Disorder With Hyperactivity

    phase 3 small molecule completed

    1 trial

  2. AEVI-001

    Avalo

    Attention Deficit Hyperactivity Disorder

    phase 2 small molecule completed

    2 trials

  3. AVTX-002

    Avalo

    Non-Eosinophilic Asthma

    phase 2 small molecule completed

    1 trial

  4. AVTX-009 Regimen 1

    Avalo

    Hidradenitis Suppurativa

    phase 2 small molecule completed

    1 trial

  5. CERC-002

    Avalo

    COVID-19 Pneumonia

    phase 2 small molecule completed

    1 trial

  6. CERC-301

    Avalo

    Major Depressive Disorder

    phase 2 small molecule completed

    2 trials

  7. FP01

    Avalo

    Acute Cough

    phase 2 small molecule completed

    1 trial

  8. FP01

    Avalo

    Chronic Refractory Cough

    phase 2 small molecule completed

    1 trial

  9. MDGN201 TARGTEPO

    Avalo

    Anemia of End Stage Renal Disease

    phase 2 mab terminated

    1 trial

  10. Placebo to AVTX-009, AVTX-009

    Avalo

    Hidradenitis suppurativa (HS)

    phase 2 small molecule active

    1 trial

  11. AEVI-007

    Avalo

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  12. CERC-006

    Avalo

    Lymphatic Malformation

    phase 1 small molecule terminated

    1 trial

  13. FP01

    Avalo

    Healthy

    phase 1 small molecule completed

    1 trial

  14. MDGN-002

    Avalo

    Crohn Disease

    phase 1 small molecule terminated

    1 trial

  15. NFC-1

    Avalo

    Attention-deficit Hyperactivity Disorder (ADHD)

    phase 1 small molecule completed

    1 trial

  16. NFC-1

    Avalo

    22q11.2 Deletion Syndrome

    phase 1 small molecule completed

    1 trial

  17. NFC-1 100 mg

    Avalo

    Attention Deficit Disorder With Hyperactivity

    phase 1 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12410153

    Compounds, compositions and methods

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12331107

    Methods of treating pneumonia or respiratory failure associated with COVID-19 by administering an anti-LIGHT antibody

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11939368

    QTY Fc fusion receptor proteins

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11898180

    Compositions and methods for amino acid depletion therapy

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11850243

    Dihydropyridine compositions and methods for treating neurological disorders

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11708406

    Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11555060

    QTY FC fusion water soluble receptor proteins

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11479576

    Nucleic acid prodrugs

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Avalo?

Avalo (AVTX) is a pharma company. headquartered in WAYNE, PA, USA. listed on NYSE. NovaPharmaNews links 17 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Avalo sponsor?

We track 17 ClinicalTrials.gov-linked programs for Avalo, including NFC-1 and 16 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Avalo company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.